Crossmark

Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ST258 isolated from a Japanese patient without a history of foreign travel - a new public health concern in Japan: a case report

Crossref DOI link: https://doi.org/10.1186/s12879-018-3649-9

Published Online: 2019-01-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ainoda, Yusuke https://orcid.org/0000-0002-1009-8414
Aoki, Kotaro

Ishii, Yoshikazu

Okuda, Kentaro

Furukawa, Hitomi

Manabe, Ryo

Sahara, Toshinori

Nakamura-Uchiyama, Fukumi

Kurosu, Hitomi

Ando, Yukiko

Fujisawa, Maki

Hoshino, Hitomi

Arima, Hideki

Ohnishi, Kenji
License Information

Text and Data Mining valid from 2019-01-07
More Information

Article History

Received: 3 April 2018

Accepted: 21 December 2018

First Online: 7 January 2019

Ethics approval and consent to participate

: The study was in accordance with the tenets of the Declaration of Helsinki. The requirement for approval from the Ethics Committee is unnecessary, based on the guidelines of the Ministry of Health, Labor and Welfare in Japan. The Ethics Committee at Tokyo Metropolitan Health and Medical Treatment Corporation Ebara Hospital ruled that no formal ethical approval was required for reporting this case.

: Written consent to publish the case report was obtained from the patient.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below